Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$4.63bn211.5n/a
au flag iconMSBMesoblastAU$2.83bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.04bnn/an/a
au flag iconPYCPYC TherapeuticsAU$715.44mn/an/a
au flag iconIMMImmutepAU$335.89mn/an/a
au flag iconDXBDimerixAU$308.23mn/an/a
au flag iconCGSCogstateAU$297.31m20.11.12%
au flag iconRACRace OncologyAU$279.73mn/an/a
au flag iconTTXTetratherixAU$200.82mn/an/a
au flag iconATHAlterity TherapeuticsAU$114.09mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$105.15mn/an/a
au flag iconLTPLtr PharmaAU$104.97mn/an/a
au flag iconALAArovella TherapeuticsAU$99.84mn/an/a
au flag iconBXNBioxyneAU$86.59m17.54n/a
au flag iconACWActinogen MedicalAU$85.78mn/an/a
au flag iconILAIsland PharmaceuticalsAU$69.65mn/an/a
au flag iconATXAmplia TherapeuticsAU$64.01mn/an/a
au flag iconIMUImugeneAU$62.36mn/an/a
au flag iconADOAnteotechAU$62.22mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a